DECEMBER - 20235TECH OUTLOOKCXO INSIGHTS3D bioprinting: Accelerating Drug DiscoveryItedale Namro Redwan, CSO, CELLINK28Ensuring Safe Drug Development with Regulatory ComplianceEnrique Blanco, Director of Operations, Grupo Loeffler-Russek23How to Drive Patient-Centred Clinical InnovationsLiselotte Hyveled, Chief Patient Officer, Principal Vice President and Board member, Novo Nordisk A/S21Speed, Safety and Scalability: In Integrative Approach to Drug DevelopmentLinda Cherry, Vice President and Doug Niven, PhD, Executive Director, Syneos Health19The Rise in Outsourcing Clinical TrialsErika Vento-Gaudens, Vice President, Global Clinical Operations, Guardant Health27GenemarkersDr. Anna Langerveld,Founder and CEO18TOP 10PHARMACOGENOMICSERVICES PROVIDERS - 2023Personalized Medicine Care Diagnostics Laboratory (PMCDx)Sherry Dadgar, Ph. D.,Founder and CEO25Coriell Life SciencesScott Megill, President and CEO26
< Page 4 | Page 6 >